Rosacea is a very common skin condition that in some form affects a reported 4 million men and women in the UK and Ireland due to our fair skin complexions, but is almost 3 times more common in women 30 to 55. However, men often suffer more severe symptoms. The long-term effects of rosacea can make people’s lives a misery and there are plenty of products out there on the market that claim to relieve symptoms but, in reality, relief is minimal.
However, help is now at hand for sufferers from a new product called Rosacure® (Synchrorose® the clinical strength version) that is specially formulated for rosacea. Its unique formula also helps with excessive blushing and flushing. This revolutionary new clinical strength Rosacea treatment contains patented ingredients to suppress rosacea symptoms and also underlying causes and is only available in professional skin clinics.
One of the main triggers of rosacea is UV radiation, which many of us don’t think we are at risk of living in rainy British Isles. However, 90 per cent of UV rays can penetrate through cloud cover and this little known fact means that we are one of the worst nations for protecting our skin on a daily basis from damaging UV rays. And if you are have sun sensitive skin then this prolonged exposure in the first third of life is a key cause in the development of rosacea.
Rosacea is a long-term skin disorder that causes the facial skin tissue to redden, predominantly on the cheeks, nose and also on the forehead and chin. Inflammation of the underlying tissues, including the blood vessels, also occurs and in the early stages skin redness may appear as periodic blushing attacks. However, as the condition progresses sufferers may see angry, below the surface spots and surface water filled pustules can develop, as well as blood vessels becoming more pronounced which show as thread veins on the surface of the skin.
Rosacea tends to run in families and as a result many people mistakenly believe that their ruddy complexion is simply a family characteristic that they must learn to live with. The degree of reddening and the length of an episode tend to increase as our hormonal status alters in life.
In at least 10 per cent of cases rosacea can cause acne-like eruptions with pustules and lumps, and in one per cent, can cause eye problems such as redness, dryness, itching, burning, excess tears and the feeling of having sand in the eye. The eyelids may become inflamed and swollen and the eyes become sensitive to light.
Rosacure® (Synchrorose® the clinical strength version) helps sufferers by reducing reddening and swelling, increasing the skins resistance and decreasing its sensitivity to triggers. Rosacure® (Synchrorose® the clinical strength version) also helps to protect by nourishing the skin and improving the skin quality, resulting in more tolerant and calmer skin and making it more resistant to damage, such as thread veins, and encourages recovery.
Two new ingredients have been added to Rosacure® (Synchrorose® the clinical strength version) existing ingredients. The first is a world first patented ingredient, clinically proven in rosacea studies by top dermatologists and research scientists, to be the first known agent to interrupt the rosacea development process. All previous and existing products targets the redness once stimulated. It works by blocking tiny protein fragments which are produced by nerve stimulation in itself triggered by common dietary triggers and internal bodily triggers. Theses protein fragments initiate the reddening process. By blocking them we can stop the reddening episode initiating.
The second new ingredient which improves skin tolerance to external triggers such as wind and UV but also improves hydration and skin texture.
Rosacure® (Synchrorose® the clinical strength version) is made using ingredients pharmaceutically isolated and purified which can visibly reduce permanent and intermittent redness in just 10 to 14 days. (average 2 to 6 weeks). Continued improvement is seen with continued use.
Peter Roberts, managing director of SkinMed who market Rosacure® (Synchrorose® the clinical strength version) , said: “Rosacea is a common skin condition that people need no longer suffer from. Whilst it is not life threatening, the disorder is debilitating as sufferers have to make changes to their lifestyle, for example, by avoiding going out in sunny weather, avoiding alcohol or by steering clear of strenuous exercise, all of which can cause flare-ups. Rosacure® (Synchrorose® the clinical strength version) is revolutionary as it uses a new combination of active ingredients that help to visibly reduce redness and provide relief at a rate that has not been available before.”